High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater-Reference-Cited by-同舟云学术

High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater

Published:2019-08-09 Issue:1 Volume:17 Page:
ISSN:1477-7819
Container-title:World Journal of Surgical Oncology
language:en
Short-container-title:World J Surg Onc

Author:

Murakami Takashi,Matsuyama Ryusei,Ueda Michio,Mochizuki Yasuhisa,Homma Yuki,Kameda Kunio,Yazawa Keiichi,Izumisawa Yusuke,Fukushima Tadao,Kamimukai Nobuyuki,Yoshida Kenichi,Kamiya Noriyuki,Hoffman Robert M.,Endo Itaru^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1186/s12957-019-1675-8.pdf

Reference35 articles.

1. Ahn DH, Bekaii-Saab T. Ampullary cancer: an overview. Am Soc Clin Oncol Educ Book. 2014:112–5.

2. Ishihara S, Horiguchi A, Miyakawa S, Endo I, Miyazaki M, Takada T. Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci. 2016;23(3):149–57.

3. Riall TS, Cameron JL, Lillemoe KD, Winter JM, Campbell KA, Hruban RH, et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery. 2006;140(5):764–72.

4. Yoon Y-S, Kim S-W, Park SJ, Lee HS, Jang J-Y, Choi MG, et al. Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy. Ann Surg. 2005;242(1):92–100.

5. Wu T, Zhang W, Yang G, Li H, Chen Q, Song R, et al. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review. Oncotarget. 2016;7(31):50417–27.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival benefit of adjuvant treatment for ampullary cancer with lymph nodal involvement: A systematic review and meta-analysis;Hepatobiliary & Pancreatic Diseases International;2024-07

2. Evaluation of RUNX2 and HMGB1 expression as markers of tumor aggressiveness in urothelial carcinoma;Egyptian Journal of Pathology;2022

3. Efficacy and safety of adjuvant therapy after curative surgery for ampullary carcinoma: A systematic review and meta-analysis;Surgery;2021-10

4. Combined treatment for cancer of the ampulla of Vater;Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery;2021-06-21

5. HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway;Experimental and Therapeutic Medicine;2021-05-02